Authors/Disclosures
|
Deniz Erten-Lyons, MD, FAAN
(FDA)
|
Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals. |
|
Ashkan Mowla, MD, FAAN
|
No disclosure on file |
|
Patricia L. Kramer, PhD
(Oregon Health Sciences University)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Beth Wilmot, MS
(Oregon Health & Science University)
|
No disclosure on file |
|
|
No disclosure on file |
|
Christopher J. Deline, MD
|
No disclosure on file |
|
Jeffrey A. Kaye, MD, FAAN
(Oregon Hlth Sci Univ.)
|
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
|
Marilou I. Ching, MD
(Chingbingyong)
|
Dr. Ching has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Robert N. Sawyer, Jr., MD
|
Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson. |